BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1729620)

  • 1. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
    N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
    Khabbaz RF; Douglas JM; Judson FN; Spiegel RA; St Louis ME; Whittington W; Hartley TM; Lairmore M; Kaplan JE
    J Infect Dis; 1990 Jul; 162(1):241-4. PubMed ID: 2192006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
    Olaleye OD; Ekweozor CC
    Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of human T cell leukaemia/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia.
    Poljak M; Bednarik J; Rednak K; Seme K; Kristancic L; Celan-Lucu B
    Folia Biol (Praha); 1998; 44(1):23-5. PubMed ID: 10730871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
    Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
    J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
    Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
    Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HTLV types I and II among drug users in King County, Washington.
    Thiede H; Harris NV; McGough JP; Roberts B; Khabbaz RF; Kaplan JE
    West J Med; 1994 Jun; 160(6):540-4. PubMed ID: 8053176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
    Christiansen CB
    Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.
    Bellei NC; Granato CF; Tomyiama H; Castelo A; Ferreira O
    Trans R Soc Trop Med Hyg; 1996; 90(2):122-5. PubMed ID: 8761567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human T-lymphotropic virus I/II detection in Chilean patients from Sexually Transmitted Diseases clinics].
    Sanhueza D; Ramírez E; Navarrete N; Santander E; Garmendia ML; Martínez MJ
    Rev Med Chil; 2012 Oct; 140(10):1239-44. PubMed ID: 23559279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden.
    Malm K; Ekermo B; Hillgren K; Britton S; Fredlund H; Andersson S
    Scand J Infect Dis; 2012 Nov; 44(11):852-9. PubMed ID: 22803699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.